Literature DB >> 25468807

Elevated diastolic but not systolic blood pressure increases mortality risk in hypertensive but not normotensive patients with acute ischemic stroke.

Konstantinos Tziomalos1, Vasilios Giampatzis2, Stella D Bouziana2, Marianna Spanou2, Maria Papadopoulou2, Stavroula Kostaki2, Vasiliki Dourliou2, Marianthi Papagianni2, Christos Savopoulos2, Apostolos I Hatzitolios2.   

Abstract

BACKGROUND: The relationship between blood pressure (BP) at admission for acute ischemic stroke and outcome is controversial. We aimed to assess whether only systolic BP (SBP), only diastolic BP (DBP), both or neither predict outcome and whether these associations differ between patients with and without a history of hypertension.
METHODS: We prospectively studied all patients who were admitted with acute ischemic stroke (n = 415; 39.5% males, age 78.8 ± 6.6 years). The severity of stroke was assessed at admission with the National Institutes of Health Stroke Scale (NIHSS). The outcome was evaluated with dependency at discharge (modified Rankin scale between 2 and 5) and in-hospital mortality.
RESULTS: In the total study population, independent predictors of dependency at discharge were age, history of prior ischemic stroke, and NIHSS score at admission. Independent predictors of in-hospital mortality were DBP at admission and NIHSS score at admission. In patients with a history of hypertension (n = 343), independent predictors of dependency at discharge were age and NIHSS score at admission whereas independent predictors of in-hospital mortality were DBP at admission and NIHSS score at admission. In patients without a history of hypertension (n = 72), the only independent predictor of dependency at discharge and in-hospital mortality was the NIHSS score at admission.
CONCLUSIONS: Higher DBP at admission predict in-hospital mortality in patients with acute ischemic stroke whereas SBP in the acute phase is not associated with short-term outcome. The relationship between DBP at admission and outcome appears to be more prominent in hypertensive patients. © American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  blood pressure; cerebral flow autoregulation; hypertension; ischemic stroke; outcome; severity.

Mesh:

Year:  2014        PMID: 25468807     DOI: 10.1093/ajh/hpu234

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  5 in total

1.  The Relationship Between Admission Blood Pressure and Clinical Outcomes for Acute Basilar Artery Occlusion.

Authors:  Yuhong Cao; Rongzong Li; Shunfu Jiang; Jing Guo; Xiaojun Luo; Jian Miao; Jincheng Liu; Bo Zheng; Jie Du; Yuxian Zhang; Shunyu Yang; Li Wang; Wenjie Zi; Qingwu Yang; Jun Luo; Guohui Jiang
Journal:  Front Neurosci       Date:  2022-06-21       Impact factor: 5.152

Review 2.  Asking the Patient or Measuring Blood Pressure in the Emergency Department: Which One is Best?

Authors:  Per H Skoglund; Per Svensson
Journal:  Curr Hypertens Rep       Date:  2016-07       Impact factor: 5.369

3.  Non-cardioembolic stroke/transient ischaemic attack in Asians and non-Asians: A post-hoc analysis of the PERFORM study.

Authors:  Takao Hoshino; Leila Sissani; Julien Labreuche; Marie-Germaine Bousser; Angel Chamorro; Marc Fisher; Ian Ford; Kim M Fox; Michael G Hennerici; Heinrich P Mattle; Peter M Rothwell; Philippe Gabriel Steg; Eric Vicaut; Pierre Amarenco
Journal:  Eur Stroke J       Date:  2018-08-24

4.  Human Urinary kallidinogenase promotes good recovery in ischemic stroke patients with level 3 hypertension.

Authors:  Danhong Wu; Yi Lyu; Ping Zhong; Fengdi Liu; Xueyuan Liu
Journal:  Brain Behav       Date:  2017-06-21       Impact factor: 2.708

5.  Temporal profiles of blood pressure, circulating nitric oxide, and adrenomedullin as predictors of clinical outcome in acute ischemic stroke patients.

Authors:  Marta Serrano-Ponz; Carmen Rodrigo-Gasqué; Eva Siles; Esther Martínez-Lara; Laura Ochoa-Callejero; Alfredo Martínez
Journal:  Mol Med Rep       Date:  2016-03-18       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.